RxDoctor Payments Data

Stephen Jaffe, MD

Diagnostic Radiology · Bryn Mawr, PANPI 1467489062

Payments from drug & device makers

What this record shows

This record is dominated by grants: $18,182 of the $18,502 with a category attached, or 98.3%. Abbott accounts for 99.9% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2024 at $18,182 and has fallen 98.3% since, to $300 in 2025. Among diagnostic radiology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,502in general payments, 2019–2025

Across 8 payments — averaging $2312.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$18K
  • Medtronic$20

What the payments were for

  • Grants$18,18298%
  • Food & beverage$3202%

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott7$18,482
Medtronic1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,502 in reported general payments places this provider in the 95th percentile of 1,665 diagnostic radiology providers in Pennsylvania.

See all diagnostic radiology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$328,542
Medicare patients
1,598
Services billed
26,096

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Guanfacine Hcl ErGuanfacine Hcl19$284

Paid to pharmacies, not to this prescriber.

Other diagnostic radiology in Bryn Mawr

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →